NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/18/2024
Back to search
Official data from USPTO
BIOCURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/18/2024
Trademark type
Combined
Nice classes
35
Filing date
07/15/2016
Registration date
10/17/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2024
Last transaction
01/18/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2012
First use in commerce
04/01/2012
Drawing code
3
Owner type
16
Owner location
Houston, TX, US
Examiner
TRIPI, CYNTHIA
Law office
M90
Current location
TMO LAW OFFICE 118
Mark description
The mark consists of the word "BIOCURE" and the symbol of a "DNA" vector to the left of the word. The letter "R" in the word "BIOCURE" is stylized with an "X" incorporated in the letter to look like the symbol "RX".
Holders and representatives
Holders
BioCure LLC
Representatives
Alberto Q. Amatong, Jr. AMATONG MCCOY LLC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services; specialty pharmacy servicesspecialized retail pharmacy services for patients with particular medical conditions
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/18/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/12/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/13/2023
E815
TEAS SECTION 8 & 15 RECEIVED
04/12/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/17/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/08/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/02/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/30/2017
IUAF
USE AMENDMENT FILED
08/11/2017
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2016
PUBO
PUBLISHED FOR OPPOSITION
12/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/16/2016
ALIE
ASSIGNED TO LIE
11/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
10/26/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/26/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
10/26/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/26/2016
DOCK
ASSIGNED TO EXAMINER
10/26/2016
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/21/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2016
NWAP
NEW APPLICATION ENTERED
07/19/2016
Continuous trademark protection
Get notified about every new filing that threatens BIOCURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.